Swedencare AB (publ) (FRA:7XY)

Market Cap	398.74M -32.0%
Revenue (ttm)	246.10M +4.6%
Net Income	4.49M -46.8%
EPS	0.03 -47.1%
Shares Out	n/a
PE Ratio	88.75
Forward PE	22.58
Dividend	0.28 (11.41%)
Ex-Dividend Date	Apr 24, 2026

Volume	n/a
Average Volume	0
Open	2.380
Previous Close	2.455
Day's Range	2.380 - 2.380
52-Week Range	2.075 - 4.265
Beta	n/a
RSI	54.70
Earnings Date	Apr 2, 2026

About Swedencare AB

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and suppo...

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Employees: 609
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7XY

Financial Performance

In 2025, Swedencare AB's revenue was 2.69 billion, an increase of 6.13% compared to the previous year's 2.54 billion. Earnings were 55.50 million, a decrease of -43.88%.

Financial numbers in SEK